![](https://www.practical-patient-care.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
GBCAs for enhanced MRI of brain tumours
By Bracco Imaging
Miles Kirchin from the division of global medical and regulatory affairs at Bracco Imaging reports the results of a study into the relative efficacy of non-ionic macrocyclic gadolinium-based contrast agents in brain tumour MRI.
![](https://www.practical-patient-care.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)